Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse MKT  >  TransEnterix, Inc.    TRXC

TRANSENTERIX, INC.

(TRXC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo TransEnterix, Inc.
TransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Number of employees : 163 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Systems18.7577.8%5.5565% -70.4%
Instruments and Accessories4.3117.9%1.5618.2% -63.9%
Services1.054.3%1.4316.7% +36.56%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
Asia1.456%4.6955% +224.46%
Europe18.8078%3.3339% -82.3%
United States3.8616%0.5126% -86.73%
Managers
NameAgeSinceTitle
Anthony Fernando472019President, Chief Executive Officer & Director
Paul Arthur LaViolette612013Chairman
Shameze Rampertab532020Chief Financial Officer & Executive Vice President
Jane H. Hsaio, Dr.712005Independent Director
David B. Milne562013Independent Director
Richard C. Pfenniger632005Independent Director
William N. Starling652006Independent Director
William N. Kelley, Dr.792015Independent Director
Andrea Biffi372015Independent Director
Joshua B. Weingard462013Secretary & Chief Legal Officer
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 99,876,465 95,618,009 95.7% 0 0.0% 95.7%
Shareholders
NameEquities%
Empery Asset Management LP 8,571,428 8.58%
Heights Capital Management, Inc. 8,002,857 8.01%
Sabby Capital LLC 1,760,262 1.76%
Gregory R Ammon 1,629,431 1.63%
Synergy Life Science Partners LLC 1,573,218 1.58%
The Big Flower Trust 1,565,219 1.57%
Sofar SpA 1,482,008 1.48%
Masters Capital Management LLC 900,000 0.90%
The Vanguard Group, Inc. 645,890 0.65%
First Trust Advisors LP 618,481 0.62%
Company contact information
TransEnterix, Inc.
635 Davis Drive
Suite 300
Morrisville, NC 27560

Phone : +1.919.765.8400
Fax : +1.919.765.8459
Web : http://www.transenterix.com
Sector Medical Equipment, Supplies & Distribution - NEC
1st jan.Capitalization (M$)
TRANSENTERIX, INC.-73.05%40
ABBOTT LABORATORIES25.49%192 988
MEDTRONIC PLC-4.87%145 102
BECTON, DICKINSON AND COMPANY-11.02%70 148
HOYA CORPORATION14.78%42 115
BAXTER INTERNATIONAL INC.-4.32%40 504
DEXCOM, INC.91.09%40 020
ALIGN TECHNOLOGY, INC.62.88%35 809
SARTORIUS STEDIM BIOTECH120.85%35 534
ZIMMER BIOMET HOLDINGS-6.79%28 886
TERUMO CORPORATION1.13%27 889
WEST PHARMACEUTICAL SERVICES, INC.87.54%20 684
AMERISOURCEBERGEN CORPORATION15.70%20 081
SYSMEX CORPORATION33.57%19 778
BIO-RAD LABORATORIES, INC.57.78%17 284
STERIS PLC22.31%15 856
AVANTOR, INC.36.25%14 260
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED55.90%13 802
LIVONGO HEALTH, INC.445.37%13 709
DENTSPLY SIRONA INC.-15.87%10 403
REPLIGEN CORPORATION91.94%9 321